How to Run Country Feasibility for a Multi-Country Trial
Country feasibility answers one question: where can this protocol be delivered on time with the patients it needs. A structured approach keeps the decision objective.
What feasibility should cover
- Patient availability, local standard of care and how it compares with the protocol.
- Investigator interest, experience and capacity at each candidate site.
- Competing studies in the same indication and their effect on recruitment.
- Regulatory and ethics route, translation needs and investigational product logistics.
Data to collect from sites
- Number of eligible patients seen per year, and how patients would be identified.
- Equipment, laboratory and pharmacy capabilities needed for the protocol.
- Staffing, other ongoing trials and the time needed for contracts and approvals.
How to compare countries
- Score countries on the same criteria, and weigh each criterion according to your protocol.
- Combine countries with different strengths, for example EU countries using CTIS and non-EU countries with national procedures, to spread risk.
- Revisit the plan if enrolment lags, and add or replace sites early.
Common mistakes
- Using optimistic enrolment estimates from a single investigator.
- Ignoring competing trials or seasonal effects.
- Leaving import, labelling and storage questions until after approval.
Discuss your study
Share your protocol synopsis and target countries, and we will respond with a feasibility view.
Request a proposal Contact usRelated reading
- Clinical Trial Start-Up in Eastern Europe: A Sponsor Checklist
- CTIS Submissions in Latvia, Lithuania and Poland: What Sponsors Should Prepare
- Planning Clinical Trials Outside the EU: Georgia and Ukraine
Last reviewed 1 October 2026. This is general information, not regulatory or legal advice. Requirements change, so confirm current rules for your protocol.